Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson N Stone

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
The Journal of Urology|May 11, 2019
Reply by AuthorsNelson N Stone, E David Crawford, Vassilios M Skouteris, et al.
Urology|June 12, 2017
The 3DBiopsy Prostate Biopsy System: Preclinical Investigation of a Needle, Actuator, and Specimen Collection Device Allowing Sampling of Individualized Prostate Lengths Between 20 and 60 mmNelson N Stone, Vladimir Mouraviev, David Schechter, et al.
International Journal of Radiation Oncology, Biology, Physics|May 11, 2007
A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapyJamie A Cesaretti, Richard G Stock, David P Atencio, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomesNelson N Stone, Louis Potters, Brian J Davis, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapyChristopher A Peters, Richard G Stock, Jamie A Cesaretti, et al.
Radiation Research|June 28, 2008
Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancerRyan J Burri, Richard G Stock, Jamie A Cesaretti, et al.
Surgery Open Science|July 22, 2022
Remote surgical education using synthetic models combined with an augmented reality headsetNelson N Stone, Michael P Wilson, Steven H Griffith, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2008
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapyNelson N Stone, Louis Potters, Brian J Davis, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variableLouis Potters, Mack Roach, Brian J Davis, et al.
Urology|July 17, 2012
Role of testosterone in managing advanced prostate cancerKyle O Rove, Frans M Debruyne, Bob Djavan, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
The Journal of Urology|May 11, 2019
Reply by AuthorsNelson N Stone, E David Crawford, Vassilios M Skouteris, et al.
Urology|June 12, 2017
The 3DBiopsy Prostate Biopsy System: Preclinical Investigation of a Needle, Actuator, and Specimen Collection Device Allowing Sampling of Individualized Prostate Lengths Between 20 and 60 mmNelson N Stone, Vladimir Mouraviev, David Schechter, et al.
International Journal of Radiation Oncology, Biology, Physics|May 11, 2007
A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapyJamie A Cesaretti, Richard G Stock, David P Atencio, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomesNelson N Stone, Louis Potters, Brian J Davis, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapyChristopher A Peters, Richard G Stock, Jamie A Cesaretti, et al.
Radiation Research|June 28, 2008
Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancerRyan J Burri, Richard G Stock, Jamie A Cesaretti, et al.
Surgery Open Science|July 22, 2022
Remote surgical education using synthetic models combined with an augmented reality headsetNelson N Stone, Michael P Wilson, Steven H Griffith, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2008
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapyNelson N Stone, Louis Potters, Brian J Davis, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variableLouis Potters, Mack Roach, Brian J Davis, et al.
Urology|July 17, 2012
Role of testosterone in managing advanced prostate cancerKyle O Rove, Frans M Debruyne, Bob Djavan, et al.
Pageof 12